title: References - Neonatal Intensive Care Drug Manual
text: |
  Neonatal Intensive Care Drug Manual
  |
  bet | 428/654 | Sana | 03.01.2022 | Hajmi | 1,5 Mb. | | #14803 |
  References
  |
  Kelly MA & Finer NN: Nasotracheal intubation in the neonate: physiologic responses and effects of atropine and pancuronium. J Pediatr 1984; 105:303-309.
  Cools F, Offringa M. Neuromuscular paralysis for newborn infants receiving mechanical ventilation. Cochrane Database of Systematic Reviews 2005, Issue 2. Art. No.: CD002773. DOI: 10.1002/14651858.CD002773.pub2.
  Burger,R. Paralysis of ventilated newborn babies does not influence resistance of the total respiratory system. European Respiratory Journal. 14(2):357-62, 1999 Aug.
  Cheung PY, Tyebkhan JM, Peliowski A, Ainsworth W, Robertson CM. Prolonged use of pancuronium bromide and sensorineural hearing loss in childhood survivors of congenital diaphragmatic hernia. Journal of Pediatrics. 135(2 Pt 1):233-9, 1999 Aug.
  Rossiter A, Souney PF, McGowan S, Carvajal P. Pancuronium induced prolonged neuromuscular blockade. Crit Care Med 1991;19:1583–7.
  Fanconi S, Ensner S, Knecht B. Effects of paralysis with pancuronium bromide on joint mobility in premature infants. J Pediatr 1995;127:134–6.
  Johnson PN, Miller J, Gormley AK. Continuous-Infusion Neuromuscular Blocking Agents in Critically Ill Neonates and Children. Pharmacotherapy 31 (6): 609-620 2011
  Tobias JD, Lynch A, McDuffee A, Garrett JS. Pancuronium infusion for neuromuscular block in children in the pediatric intensive care unit. Anesth Analg 1995;81:13–16.
  de Lemos JM, Carr RR, Shalansky KF, Bevan DR, Ronco JJ. Paralysis in the critically ill: intermittent bolus pancuronium compared with continuous infusion. Critical Care Medicine 1999. 27(12):2648-55..
  Product Information. AusDI [Internet]. Sydney: Phoenix Medical Publishing; 2006. Updated 23/09/13.
  Australian Injectable Drugs Handbook. Accessed on 14th December 2016.
  Ramsey FM: Basic pharmacology of neuromuscular blocking agents. Anesth Clin North Am 1993; 11(2):219-235.
  AMA Department of Drugs: AMA Drug Evaluations, 5th. American Medical Association, Chicago, IL, 1983.
  Doherty WG, Breen PJ, Donati F, et al: Accelerated onset of pancuronium with divided doses. Can Anaesth Soc J 1985; 32:1-4.
  Micomedex solutions. Accessed on 14th December 2016.
  Berthier JC, Bourgeois J, Sann L, Frappaz D, Damon G, Cochat P, Bethenod M. [Prolonged curarization in the newborn infant under assisted ventilation for idiopathic respiratory distress]. Arch Fr Pediatr. 1983;40:79-83.
  Greenough A, Gamsu HR, Greenall F. Investigation of the effects of paralysis by pancuronium on heart rate variability, blood pressure and fluid balance. Acta paediatrica Scandinavica. Nov 1989;78(6):829-834
  Murray MJ, Cowen J, DeBlock H, et al. Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Critical care medicine. Jan 2002;30(1):142-156.
  |
  Original version Date: 2014
  |
  Author: AK, JD
  |
  Current Version number: 2
  |
  Current Version Date: 2/3/2021
  |
  Risk Rating: Medium
  |
  Due for Review: 2/3/2024
  |
  Approved by: DTC
  |
  Approval Date: TBA
  |
  |
  | |